Advertisements


Viking Therapeutics: Partnerships, Abstracts, And Endpoints

Viking Therapeutics: Partnerships, Abstracts, And Endpoints.....»»

Category: topSource: seekingalphaNov 9th, 2018

Viking Therapeutics says VK2809 study achieves primary, secondary endpoints

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall16 hr. 53 min. ago

Viking Shares Jump After Fatty Liver Drug Meets Midstage Trial Endpoints

Viking Therapeutics Inc (NASDAQ: VKTX) shares have raced away Tuesday following the read more.....»»

Category: blogSource: benzingaSep 18th, 2018

Why Viking Therapeutics Shares Are Finding Renewed Buying Interest

Viking Therapeutics Inc (NASDAQ: VKTX) shares — which cooled off following an 87-percent jump Sept. read more.....»»

Category: blogSource: benzinga2 hr. 23 min. ago

Viking Therapeutics: Year In Review

Viking Therapeutics: Year In Review.....»»

Category: topSource: seekingalpha2 hr. 53 min. ago

Viking Therapeutics data mitigates perceived safety risk, says William Blair

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall4 hr. 38 min. ago

Viking Therapeutics Stock Sees Short Interest Jump 12.2%

Market News Video.....»»

Category: topSource: redinews22 hr. 7 min. ago

Viking Therapeutics (VKTX) CEO Brian Lian on Q3 2018 Results - Earnings Call Transcript

Viking Therapeutics (VKTX) CEO Brian Lian on Q3 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaNov 7th, 2018

Viking Therapeutics: A Valuation

Viking Therapeutics: A Valuation.....»»

Category: topSource: seekingalphaOct 19th, 2018

Hedge Fund and Insider Trading News: Andreas Halvorsen, Bill Ackman, Paulson & Co., Merck & Co., Inc. (MRK), Arvinas Inc (ARVN), Y-mAbs Therapeutics (YMAB), and More

Andreas Halvorsen Discloses Stake In Urovant Sciences (Forbes.com) Andreas Halvorsen’s Viking Global Investors disclosed Thursday that it holds.....»»

Category: topSource: insidermonkeyOct 13th, 2018

Here"s Why Viking Therapeutics Skyrocketed 33% in September

Solid phase 2 data has investors excited about the biotech's future......»»

Category: topSource: foxnewsOct 11th, 2018

Viking Therapeutics presents "positive" data from in vivo study of VK2809

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 8th, 2018

Global Blood Therapeutics to present three SCD abstracts at SCDAA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 4th, 2018

Viking Therapeutics: VK2809 Phase 2 study results selected for presentation

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 4th, 2018

Viking Therapeutics data increase partnership potential, says William Blair

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 1st, 2018

Viking Therapeutics price target raised to $31 from $28 at H.C. Wainwright

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 1st, 2018

Viking Therapeutics says Phase 2 study of VK5211 achieves primary endpoint

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 1st, 2018

Viking Therapeutics stock jumps 4.8% premarket on news of positive trial results

Viking Therapeutics Inc. shares surged x% in premarket trade Monday, after the company reported positive results in a mid-stage trial of a treatment for broken hips. The company said its Phase 2 trial of VK5.....»»

Category: topSource: marketwatchOct 1st, 2018

Viking Therapeutics stock jumps 4.8% premarket

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchOct 1st, 2018

CORRECTED: Viking Therapeutics reports positive results in trial of treatment for hip fracture

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchOct 1st, 2018

Viking Therapeutics And VK2809: The Hype On NASH

Viking Therapeutics And VK2809: The Hype On NASH.....»»

Category: topSource: seekingalphaSep 26th, 2018